Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Operating activities
Net income	$ 26,497	$ 19,300
Adjustments to reconcile net income to net cash provided by operating activities:
Loss on asset disposals	2	24
Depreciation of fixed assets	2,918	2,738
Amortization of internal-use software and intangibles	4,307	2,777
Amortization of developed technology acquired	498	301
Deferred income taxes	5,823	(980)
Share-based compensation	15,798	12,656
Changes in operating assets and liabilities	(21,681)	(8,840)
Net cash provided by operating activities	34,162	27,976
Investing activities
Cash paid for business combination, net of cash acquired	0	(144,945)
Capital expenditures	(1,424)	(2,082)
Additional investments in corporate-owned life insurance policies	0	(27)
Net cash used in investing activities	(1,424)	(147,054)
Financing activities
Debt proceeds, net of issuance costs	0	49,646
Debt repayments	(24,000)	(12,000)
Proceeds from Employee Stock Purchase Plan purchases	777	453
Repurchase of common shares to satisfy employee tax withholding	(1,357)	(2,848)
Net cash (used in) provided by financing activities	(24,580)	35,251
Effect of exchange rate changes on cash	254	(303)
Net increase (decrease) in cash and cash equivalents	8,412	(84,130)
Cash and cash equivalents at beginning of period	73,041	144,891
Cash and cash equivalents at end of period	$ 81,453	$ 60,761